AB Science provides an update on its masitinib clinical program


You May Also Like

Stemline Therapeutics to Present at Upcoming Investor Conferences

NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage ...

Protalix BioTherapeutics to Participate in the 14th Annual WORLDSymposium™ 2018

CARMIEL, Israel, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today ...